Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Integrative System Biology Analyses Identify Seven MicroRNAs to Predict Heart Failure.

Charrier H, Cuvelliez M, Dubois-Deruy E, Mulder P, Richard V, Bauters C, Pinet F.

Noncoding RNA. 2019 Mar 7;5(1). pii: E22. doi: 10.3390/ncrna5010022.

2.

Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure.

Dubois-Deruy E, Cuvelliez M, Fiedler J, Charrier H, Mulder P, Hebbar E, Pfanne A, Beseme O, Chwastyniak M, Amouyel P, Richard V, Bauters C, Thum T, Pinet F.

Sci Rep. 2018 Nov 29;8(1):17584. doi: 10.1038/s41598-018-35955-7.

3.

Interplay Between Phosphorylation and O-GlcNAcylation of Sarcomeric Proteins in Ischemic Heart Failure.

Mercier T, Bouvet M, Dubois-Deruy E, Dechaumes A, Beseme O, Richard V, Mulder P, Pinet F.

Front Endocrinol (Lausanne). 2018 Oct 5;9:598. doi: 10.3389/fendo.2018.00598. eCollection 2018.

4.

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Gélinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des Rosiers C, Viollet B, Sakamoto K, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L.

Nat Commun. 2018 Jan 25;9(1):374. doi: 10.1038/s41467-017-02795-4.

5.

MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure.

Dubois-Deruy E, Cuvelliez M, Fiedler J, Charrier H, Mulder P, Hebbar E, Pfanne A, Beseme O, Chwastyniak M, Amouyel P, Richard V, Bauters C, Thum T, Pinet F.

Sci Rep. 2017 Nov 7;7(1):14747. doi: 10.1038/s41598-017-15011-6. Erratum in: Sci Rep. 2018 Nov 29;8(1):17584.

6.

Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling.

Hermida N, Michel L, Esfahani H, Dubois-Deruy E, Hammond J, Bouzin C, Markl A, Colin H, Steenbergen AV, De Meester C, Beauloye C, Horman S, Yin X, Mayr M, Balligand JL.

Eur Heart J. 2018 Mar 7;39(10):888-898. doi: 10.1093/eurheartj/ehx366.

PMID:
29106524
7.

Increased level of phosphorylated desmin and its degradation products in heart failure.

Bouvet M, Dubois-Deruy E, Alayi TD, Mulder P, El Amranii M, Beseme O, Amouyel P, Richard V, Tomavo S, Pinet F.

Biochem Biophys Rep. 2016 Feb 27;6:54-62. doi: 10.1016/j.bbrep.2016.02.014. eCollection 2016 Jul.

8.

Interplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failure.

Dubois-Deruy E, Belliard A, Mulder P, Bouvet M, Smet-Nocca C, Janel S, Lafont F, Beseme O, Amouyel P, Richard V, Pinet F.

Cardiovasc Res. 2015 Jul 1;107(1):56-65. doi: 10.1093/cvr/cvv136. Epub 2015 Apr 26.

PMID:
25916824
9.

Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.

Belge C, Hammond J, Dubois-Deruy E, Manoury B, Hamelet J, Beauloye C, Markl A, Pouleur AC, Bertrand L, Esfahani H, Jnaoui K, Götz KR, Nikolaev VO, Vanderper A, Herijgers P, Lobysheva I, Iaccarino G, Hilfiker-Kleiner D, Tavernier G, Langin D, Dessy C, Balligand JL.

Circulation. 2014 Jan 28;129(4):451-62. doi: 10.1161/CIRCULATIONAHA.113.004940. Epub 2013 Nov 4.

PMID:
24190960
10.

Circulating plasma serine208-phosphorylated troponin T levels are indicator of cardiac dysfunction.

Dubois-Deruy E, Belliard A, Mulder P, Chwastyniak M, Beseme O, Henry JP, Thuillez C, Amouyel P, Richard V, Pinet F.

J Cell Mol Med. 2013 Oct;17(10):1335-44. doi: 10.1111/jcmm.12112. Epub 2013 Aug 2.

Supplemental Content

Loading ...
Support Center